A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
Objective: Although emicizumab is a bispecific, monoclonal antibody that has led to a significant improvement of treatment for hemophilia A patients with inhibitors, the routine monitoring of patients treated with emicizumab is difficult. Thrombin time (TT) reflects thrombin burst, which mainly depe...
Main Authors: | Hideo Wada, Katsuya Shiraki, Takeshi Matsumoto, Kei Suzuki, Yoshiki Yamashita, Isao Tawara, Hideto Shimpo, Motomu Shimaoka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/20/6142 |
Similar Items
-
The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate
by: Takeshi Matsumoto, et al.
Published: (2023-09-01) -
The Reevaluation of Thrombin Time Using a Clot Waveform Analysis
by: Hideo Wada, et al.
Published: (2021-10-01) -
Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura
by: Hideo Wada, et al.
Published: (2021-12-01) -
A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms
by: Mayu Kobayashi, et al.
Published: (2021-11-01) -
Expert opinion paper on the treatment of hemophilia A with emicizumab
by: Francisco-José López-Jaime, et al.
Published: (2023-12-01)